Güler S - Search Results

1

Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus.

Güler S, Cakir B, Demirbaş B, Gürsoy G, Serter R, Aral Y. Güler S, et al. Diabetes Obes Metab. 2000 Oct;2(5):313-6. doi: 10.1046/j.1463-1326.2000.00073.x. Diabetes Obes Metab. 2000. PMID: 11225747

2

Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection.

Yönem A, Cakir B, Güler S, Azal O O, Corakçi A. Yönem A, et al. Among authors: guler s. Diabetes Obes Metab. 2001 Oct;3(5):332-7. doi: 10.1046/j.1463-1326.2001.00142.x. Diabetes Obes Metab. 2001. PMID: 11703423 Clinical Trial.

3

Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis.

Cakir B, Yönem A, Güler S, Odabaşi E, Demirbaş B, Gürsoy G, Aral Y. Cakir B, et al. Among authors: guler s. Horm Res. 1999;52(6):279-83. doi: 10.1159/000023495. Horm Res. 1999. PMID: 10965207

4

Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats.

Azal O, Yönem A, Güler S, Cakir B, Baydar A, Corakçi A, Kutlu M. Azal O, et al. Among authors: guler s. Diabetes Obes Metab. 2002 Jan;4(1):75-9. doi: 10.1046/j.1463-1326.2002.00182.x. Diabetes Obes Metab. 2002. PMID: 11874446

5

Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy.

Güler S, Cakir B, Demirbas B, Yönem A, Odabasi E, Onde U, Aykut O, Gürsoy G. Güler S, et al. Horm Res. 2002;58(2):67-70. doi: 10.1159/000064664. Horm Res. 2002. PMID: 12207164 Clinical Trial.

6

Plasma tumor necrosis factor-alpha levels and insulin resistance in nondiabetic hypertensive subjects.

Demirbaş B, Güler S, Cakir B, Culha C, Aral Y. Demirbaş B, et al. Among authors: guler s. Horm Res. 2002;58(6):283-6. doi: 10.1159/000066447. Horm Res. 2002. PMID: 12446992 Clinical Trial.

7

Leptin levels increase during flutamide therapy in women with polycystic ovary syndrome.

Sahin I, Serter R, Karakurt F, Demirbas B, Guler S, Culha C, Taskapan C, Aral Y. Sahin I, et al. Among authors: guler s. Horm Res. 2003;60(5):232-6. doi: 10.1159/000074037. Horm Res. 2003. PMID: 14614228 Clinical Trial.

8

Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.

Karakurt F, Sahin I, Güler S, Demirbas B, Culha C, Serter R, Aral Y, Bavbek N. Karakurt F, et al. Among authors: guler s. Adv Ther. 2008 Apr;25(4):321-8. doi: 10.1007/s12325-008-0039-5. Adv Ther. 2008. PMID: 18389188 Clinical Trial.

9

Insulin resistance in nonobese patients with polycystic ovary syndrome.

Toprak S, Yönem A, Cakir B, Güler S, Azal O, Ozata M, Corakçi A. Toprak S, et al. Among authors: guler s. Horm Res. 2001;55(2):65-70. doi: 10.1159/000049972. Horm Res. 2001. PMID: 11509861

10

Secondary osteoporosis in women. A retrospective analysis.

Cakir B, Odabasi E, Turan M, Güler S, Kutlu M. Cakir B, et al. Among authors: guler s. Arch Gynecol Obstet. 2002 Aug;266(4):214-7. doi: 10.1007/s004040100215. Arch Gynecol Obstet. 2002. PMID: 12192482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters